ClinPGx: The Evolution of PharmGKB and CPIC - Project Summary/Abstract The success of precision medicine continues to rely on our ability to measure the genome, environment and physiological state of patients, and to select interventions that maximize efficacy and minimize adverse effects. Understanding pharmacogenomics (PGx) – the genetic influences on interindividual drug response variability – remains a critical component of precision medicine. The Clinical Pharmacogenomics Resource (ClinPGx) curators focus on high quality extraction and representation of knowledge in the primary literature, and capture information about individual genetic variations that impact drug response, the potential clinical impact of these variations, the pharmacokinetic and pharmacodynamic pathways of drug response, the PGx requirements in regulatory documents (labels), and guidelines for genome-driven prescribing. Notably, the ClinPGx website (formerly PharmGKB) user traffic generates an average of 7.7 million annual page views, excluding automated crawlers and provides flexible access to PGx knowledge on multiple devices. Most importantly, ClinPGx serves as a hub for the research community in PGx and precision medicine— integrating its contents with critical resources and organizations including ClinVar, ClinGen, the FDA, and others. Leveraging large-language models and agentic systems, we are developing tools will automate the prioritization process currently performed by the curators and is completely scalable. In this proposal, we outline our plan for the novel initiative ClinPGx to integrate PGx into the broader mission of the NIH's Clinical Genome Resource (ClinGen). ClinPGx integrates, leverages, and expands upon the successful Pharmacogenomics Knowledgebase (PharmGKB), the Clinical Pharmacogenetics Implementation Consortium (CPIC), and Pharmacogenomics Clinical Annotation Tool (PharmCAT). For the past 25 years, PharmGKB, CPIC, and PharmCAT have together served the scientific and clinical communities with an exceptional reputation and track record and are now uniquely positioned to leverage this experience and lead the PGx community and its clinical integration. In this proposal, we request support for ClinPGx, a NHGRI Genomics Community Resource, and outline a plan to: (1) develop methods and processes for automating and scaling the evidence collection for PGx knowledge curation, (2) develop standardized terminologies, frameworks, and processes to curate PGx knowledge consistent with ClinGen and accelerate the use of clinical genomic medicine, (3) evaluate PGx evidence to create clinical assertions and CPIC guidelines to support routine implementation and integration of PGx into clinical practice and genomic medicine, and (4) disseminate PGx knowledge, guidelines, and tools to support clinical PGx implementation via ClinPGx and ClinGen for the clinical genomics and scientific communities.